{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:14:35Z","timestamp":1791094475129,"version":"4.1.0"},"reference-count":71,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2011,7,13]],"date-time":"2011-07-13T00:00:00Z","timestamp":1310515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0022076","type":"journal-article","created":{"date-parts":[[2011,7,13]],"date-time":"2011-07-13T20:56:55Z","timestamp":1310590615000},"page":"e22076","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":60,"title":["Heparin Induces Harmless Fibril Formation in Amyloidogenic W7FW14F Apomyoglobin and Amyloid Aggregation in Wild-Type Protein In Vitro"],"prefix":"10.1371","volume":"6","author":[{"given":"Silvia","family":"Vilasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Sarcina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Maritato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Irace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Sirangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,7,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease.","volume":"75","author":"F Chiti","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1042\/bst0300521","article-title":"Examining the structure of the mature amyloid fibril.","volume":"30","author":"OS Makin","year":"2002","journal-title":"Biochem Soc Trans"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/jsbi.2000.4221","article-title":"Review: History of the amyloid fibril.","volume":"130","author":"JD Sipe","year":"2000","journal-title":"J Struc Bio"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature03680","article-title":"Structure of the cross-beta spine of amyloid fibrils.","volume":"435","author":"R Nelson","year":"2005","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.biochem.66.1.385","article-title":"Models of amyloid seeding in Alzheimer&apos;s disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins.","volume":"66","author":"JD Harper","year":"1997","journal-title":"Annu Rev Biochem"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/416507a","article-title":"Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases.","volume":"416","author":"M Bucciantini","year":"2002","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.","volume":"300","author":"R Kayed","year":"2003","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/418291a","article-title":"Amyloid pores from pathogenic mutations.","volume":"418","author":"HA Lashuel","year":"2002","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","article-title":"EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers.","volume":"15","author":"DE Ehrnhoefer","year":"2008","journal-title":"Nat Struct Mol Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1021\/bi0600749","article-title":"Small molecule inhibitors of <italic>\u03b1<\/italic>-synuclein filament assembly.","volume":"45","author":"M Masuda","year":"2006","journal-title":"Biochemistry"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.4161\/cc.5.14.2929","article-title":"New directions for neurodegenerative disease therapy\u2014using chemical compounds to boost the formation of mutant protein inclusions.","volume":"5","author":"RA Bodner","year":"2006","journal-title":"Cell Cycle"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1073\/pnas.0511256103","article-title":"Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington&apos;s and Parkinson&apos;s diseases.","volume":"103","author":"RA Bodner","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e5727","DOI":"10.1371\/journal.pone.0005727","article-title":"Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity.","volume":"4","author":"E Kvam","year":"2009","journal-title":"PLoS ONE"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.sbi.2008.10.001","article-title":"Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases.","volume":"18","author":"V Bellotti","year":"2008","journal-title":"Curr Opin Struct Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/path.1437","article-title":"Functional structure and composition of the extracellular matrix.","volume":"200","author":"FT Bosman","year":"2003","journal-title":"J Pathol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1110\/ps.04887005","article-title":"Amyloid accomplices and enforcers.","volume":"14","author":"AT Alexandrescu","year":"2005","journal-title":"Protein Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1474-4422(03)00484-8","article-title":"Heparan sulphate proteoglycans in Alzheimer&apos;s disease and amyloid-related disorders.","volume":"2","author":"J van Horssen","year":"2003","journal-title":"Lancet Neurol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0196-9781(02)00068-2","article-title":"Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative duiseases.","volume":"23","author":"J Diaz-Nido","year":"2002","journal-title":"Peptides"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/13506120309041728","article-title":"Amyloidogenesis: historical and modern observations point to heparin sulfate proteoglycans as a major culprit.","volume":"10","author":"JB Ancsin","year":"2003","journal-title":"Amyloid"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bbrc.2008.01.049","article-title":"Amyloidogenic properties of the prion protein fragment PrP(185\u2013208): comparison with Alzheimer&apos;s peptide Abeta(1\u201328), influence of heparin and cell toxicity.","volume":"368","author":"M Cortijo-Arellano","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"ref21","first-page":"37","article-title":"Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study.","volume":"53","author":"AD Snow","year":"1985","journal-title":"Lab Invest"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0002-9440(10)63771-6","article-title":"Inhibition of amyloid A amyloidogenesis in vivo and in tissue culture by 4-deoxy analogues of peracetylated 2-acetamido-2- deoxy-a- and b-D-glucose: Implications for the treatment of various amyloidoses.","volume":"164","author":"R Kisilevsky","year":"2004","journal-title":"Am J Pathol"},{"issue":"14","key":"ref23","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1096\/fj.03-1436fje","article-title":"Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy.","volume":"18","author":"E Elimova","year":"2004","journal-title":"FASEB J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1073\/pnas.0502287102","article-title":"In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.","volume":"102","author":"JP Li","year":"2005","journal-title":"Proc Nat Acad Sci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1046\/j.1471-4159.1999.721681.x","article-title":"The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation.","volume":"72","author":"GM Castillo","year":"1999","journal-title":"J Neurochem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1046\/j.1471-4159.1997.69062452.x","article-title":"Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer&apos;s disease, accelerates A beta fibril formation, and maintains A beta fibril stability.","volume":"69","author":"GM Castillo","year":"1997","journal-title":"J Neurochem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1432-1327.1999.00957.x","article-title":"Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans: effects on fibril nucleation and growth.","volume":"266","author":"J McLaurin","year":"1999","journal-title":"Eur J Biochem"},{"issue":"6600","key":"ref28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/383550a0","article-title":"Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans.","volume":"383","author":"M Goedert","year":"1996","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1021\/bi011711s","article-title":"Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from \u03b1-synuclein in vitro.","volume":"41","author":"JA Cohlberg","year":"2002","journal-title":"Biochemistry"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1021\/bi0519295","article-title":"Heparin accelerates gelsolyn amyloidogenesis.","volume":"45","author":"JY Suk","year":"2006","journal-title":"Biochemistry"},{"issue":"8","key":"ref31","first-page":"4912","article-title":"Heparin strongly enhances the formation of \u03b22-microglobulin amyloid fibrils in the presence of type I collagen.","volume":"283","author":"A Relini","year":"2008","journal-title":"J B C"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"12806","DOI":"10.1021\/bi0610653","article-title":"Nature and significance of the interactions between amyloid fibrils and biological polyelectrolytes.","volume":"45","author":"M Calamai","year":"2006","journal-title":"Biochemistry"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jb\/mvp128","article-title":"Amyloid formation by the model protein muscle acylphosphatase is accelerated by heparin and heparin sulfate through a scaffolding-based mechanism.","volume":"146","author":"N Motamedi-Shad","year":"2009","journal-title":"J Biochem"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00249-010-0581-3","article-title":"Comparison of aggregation enhancement and inhibition as strategies for reducing the cytotoxicity of the aortic amyloid polypeptide medin.","volume":"39","author":"J Madine","year":"2010","journal-title":"Eur Biophys J"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/emboj\/20.3.377","article-title":"Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.","volume":"20","author":"C Wong","year":"2001","journal-title":"Embo J"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"12878","DOI":"10.1016\/S0021-9258(18)98776-4","article-title":"High affinity interactions between the Alzheimer&apos;s beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan.","volume":"266","author":"S Narindrasorasak","year":"1991","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1111\/j.1471-4159.1993.tb07453.x","article-title":"pH dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans.","volume":"61","author":"KR Brunden","year":"1993","journal-title":"J Neurochem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/JVI.68.4.2135-2141.1994","article-title":"Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red.","volume":"68","author":"B Caughey","year":"1994","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"18421","DOI":"10.1074\/jbc.M110406200","article-title":"Identification of the heparan sulfate binding sites in the cellular prion protein.","volume":"277","author":"RG Warner","year":"2002","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"16611","DOI":"10.1074\/jbc.M008423200","article-title":"Identification of a heparin binding domain in the Nterminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation.","volume":"276","author":"K Park","year":"2001","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000049037","article-title":"Affinity binding of glycosaminoglycans with beta(2)-microglobulin.","volume":"90","author":"K Ohashi","year":"2002","journal-title":"Nephron"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"11184","DOI":"10.1074\/jbc.M108837200","article-title":"Cleaved beta 2- microglobulin partially attains a conformation that has amyloidogenic features.","volume":"277","author":"NH Heegaard","year":"2002","journal-title":"J Biol Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1096\/fj.09-134981","article-title":"Heparan sulphate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch.","volume":"23","author":"E Elimova","year":"2009","journal-title":"FASEB J"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"50914","DOI":"10.1074\/jbc.M207225200","article-title":"Surface-catalyzed amyloid fibril formation.","volume":"277","author":"M Zhu","year":"2002","journal-title":"J Biol Chem"},{"issue":"43","key":"ref45","doi-asserted-by":"crossref","first-page":"29921","DOI":"10.1074\/jbc.M109.018747","article-title":"Kinetic analysis of amyloid formation in the presence of heparin sulfate. Faster unfolding and change of pathway.","volume":"284","author":"N Motamedi-Shad","year":"2009","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1021\/bi101822y","article-title":"Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion.","volume":"50","author":"S Bourgault","year":"2011","journal-title":"Biochemistry"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"45887","DOI":"10.1074\/jbc.M207659200","article-title":"Tryptophanyl substitution in apomyoglobin determine protein aggregation and amyloid-like fibril formation at physiological pH.","volume":"277","author":"I Sirangelo","year":"2002","journal-title":"J Biol Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"13183","DOI":"10.1074\/jbc.M308207200","article-title":"Fibrillogenesis and cytotoxic activity of the amyloid-forming apomyoglobin mutant W7FW14F.","volume":"279","author":"I Sirangelo","year":"2004","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-1759(89)90397-9","article-title":"Re-examination and further development of a precise and rapid dye method for measuring cell growth\/cell kill.","volume":"119","author":"MB Hansen","year":"1989","journal-title":"J Immunol Methods"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1110\/ps.062471107","article-title":"Heme binding inhibits the fibrillization of amyloidogenic apomyoglobin and determines lack of aggregate cytotoxicity.","volume":"16","author":"C Iannuzzi","year":"2007","journal-title":"Protein Sci"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"11347","DOI":"10.1021\/bi034879h","article-title":"Aggregation of bovine insulin probed by DSC\/PPC calorimetry and FTIR spectroscopy.","volume":"42","author":"W Dzwolak","year":"2003","journal-title":"Biochemistry"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"15463","DOI":"10.1073\/pnas.0303758100","article-title":"Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments.","volume":"100","author":"M Fandrich","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1110\/ps.041024904","article-title":"FTIR reveals differences between native <italic>\u03b2<\/italic>-sheet proteins and amyloid fibrils.","volume":"13","author":"G Zandomeneghi","year":"2004","journal-title":"Protein Sci"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/pro.5560020312","article-title":"Thioflavine T interaction with synthetic Alzheimer&apos;s disease beta-amyloid peptides: setection of amyloid aggregation in solution.","volume":"2","author":"H Levine III","year":"1993","journal-title":"Protein Sci"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0003-2697(89)90046-8","article-title":"Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1.","volume":"177","author":"H Naiki","year":"1989","journal-title":"Anal Biochem"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00109-003-0464-5","article-title":"Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.","volume":"81","author":"M Stefani","year":"2003","journal-title":"J Mol Med"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/416507a","article-title":"Inherent toxicity of aggregates implies a common mechanism for protein misfolding disease.","volume":"416","author":"M Bucciantini","year":"2002","journal-title":"Nature"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"31374","DOI":"10.1074\/jbc.M400348200","article-title":"Prefibrillar amyloid protein aggregates share common features of cytotoxicity.","volume":"279","author":"M Bucciantini","year":"2004","journal-title":"J Biol Chem"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.","volume":"300","author":"R Kayed","year":"2003","journal-title":"Science"},{"issue":"2","key":"ref60","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1096\/fj.05-4652fje","article-title":"Tetracycline inhibits W7FW14F apomyoglobin fibril extension and keeps the amyloid protein in a pre-fibrillar, highly cytotoxic state.","volume":"20","author":"C Malmo","year":"2006","journal-title":"FASEB J"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nchembio.283","article-title":"The causative link between the structure of aberrant protein oligomers and their ability to cause cell dysfunction.","volume":"6","author":"S Campioni","year":"2010","journal-title":"Nat Chem Biol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3390\/ijms9122515","article-title":"Protein folding and misfolding on surfaces.","volume":"9","author":"M Stefani","year":"2008","journal-title":"Int J Mol Sci"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/01.ATV.9.1.21","article-title":"Molecular modeling of protein-glycosaminoglycan interactions.","volume":"9","author":"AD Cardin","year":"1989","journal-title":"Arteriosclerosis"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-1-4613-0733-4_19","article-title":"Structural properties of the heparin-binding domains of human apolipoprotein E.","volume":"243","author":"AD Cardin","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0300-9084(94)90163-5","article-title":"Identification and regulation of the high affinity binding site of the Alzheimer&apos;s disease amyloid protein precursor (APP) to glycosaminoglycans.","volume":"76","author":"G Multhaup","year":"1994","journal-title":"Biochimie"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0014-5793(97)01146-0","article-title":"Expression and analysis of heparin binding regions of the amyloid precursor protein of Alzheimer&apos;s disease.","volume":"415","author":"SS Mok","year":"1997","journal-title":"FEBS Lett"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1016\/S0021-9258(19)43709-5","article-title":"The equilibrium unfolding parameters of horse and sperm whale myoglobin.","volume":"248","author":"D Puett","year":"1973","journal-title":"J Biol Chem"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1021\/bi00287a001","article-title":"Unfolding pathway of myoglobin. Evidence for a multistate process.","volume":"22","author":"E Bismuto","year":"1983","journal-title":"Biochemistry"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.","volume":"431","author":"M Arrasate","year":"2004","journal-title":"Nature"},{"issue":"11","key":"ref70","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1073\/pnas.0511256103","article-title":"Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington&apos;s and Parkinson&apos;s diseases.","volume":"103","author":"RA Bodner","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref71","doi-asserted-by":"crossref","first-page":"e5727","DOI":"10.1371\/journal.pone.0005727","article-title":"Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity.","volume":"4","author":"E Kvam","year":"2009","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0022076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T01:20:04Z","timestamp":1638062404000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0022076"}},"subtitle":[],"editor":[{"given":"Joseph P. R. O.","family":"Orgel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,7,13]]},"references-count":71,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2011,7,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0022076","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,13]]}}}